Skip to main content
    O

    Oric Pharmaceuticals Inc (ORIC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.52
    -0.34 (-4.33%)

    Market Cap: $814.71M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Oric Pharmaceuticals Inc (ORIC) Earnings: Report Dates and Results

    Updated Aug 3, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Oric Pharmaceuticals (ORIC) is expected to report earnings on Feb 22, 2027. In the quarter ended Jun 30, 2026, Oric Pharmaceuticals reported EPS of -$0.38, below the -$0.36 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    46%(12/26)
    Avg Surprise
    -6.07%

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.41
    Range-$0.46 - -$0.35
    16 analysts
    Revenue Consensus
    N/A
    RangeN/A
    13 analysts

    Next Report

    ORIC has an expected report date of Feb 22, 2027.

    Earnings History

    Of the 26 quarters below that had an estimate, ORIC beat 12, missed 13 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2020, when EPS landed 115.38% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jun 30, 2026-$0.38-$0.36-$0.40 - -$0.30-5.56%MissN/A132 up, 7 downAug 3, 2026
    Mar 31, 2026-$0.34-$0.32-$0.37 - -$0.26-6.25%MissN/A151 up, 1 downMay 4, 2026
    Dec 31, 2025-$0.30-$0.37-$0.51 - -$0.30+18.23%BeatN/A14N/AFeb 23, 2026
    Sep 30, 2025-$0.33-$0.40-$0.47 - -$0.31+17.50%BeatN/A115 up, 3 downNov 13, 2025
    Jun 30, 2025-$0.47-$0.44-$0.53 - -$0.36-6.82%MissN/A96 up, 1 downAug 12, 2025
    Mar 31, 2025-$0.42-$0.50-$0.54 - -$0.43+16.00%BeatN/A81 up, 1 downMay 5, 2025
    Dec 31, 2024-$0.51-$0.51-$0.55 - -$0.39-0.31%MissN/A10N/AFeb 18, 2025
    Sep 30, 2024-$0.49-$0.47-$0.52 - -$0.38-4.26%MissN/A120 up, 0 downNov 12, 2024
    Jun 30, 2024-$0.45-$0.41-$0.44 - -$0.38-9.76%MissN/A90 up, 0 downAug 12, 2024
    Mar 31, 2024-$0.37-$0.43-$0.52 - -$0.39+13.95%BeatN/A91 up, 0 downMay 6, 2024
    Dec 31, 2023-$0.49-$0.49-$0.55 - -$0.440.00%In lineN/A90 up, 0 downMar 11, 2024
    Sep 30, 2023-$0.44-$0.46-$0.51 - -$0.42+4.35%BeatN/A80 up, 0 downNov 6, 2023
    Jun 30, 2023-$0.50-$0.57-$0.60 - -$0.51+12.28%BeatN/A70 up, 0 downAug 10, 2023
    Mar 31, 2023-$0.53-$0.54-$0.60 - -$0.49+1.85%BeatN/A60 up, 0 downMay 8, 2023
    Dec 31, 2022-$0.52-$0.54-$0.58 - -$0.53+3.70%BeatN/A60 up, 0 downMar 16, 2023
    Sep 30, 2022-$0.63-$0.55-$0.58 - -$0.53-14.55%MissN/A70 up, 0 downNov 7, 2022
    Jun 30, 2022-$0.51-$0.60N/A+15.00%BeatN/AN/A0 up, 0 downAug 11, 2022
    Mar 31, 2022-$0.59-$0.57-$0.61 - -$0.51-3.51%MissN/A71 up, 0 downMay 9, 2022
    Dec 31, 2021-$0.58-$0.57-$0.71 - -$0.49-1.75%MissN/A70 up, 0 downMar 21, 2022
    Sep 30, 2021-$0.47-$0.58-$0.64 - -$0.53+18.97%BeatN/A7N/ANov 8, 2021
    Jun 30, 2021-$0.57-$0.49-$0.53 - -$0.47-16.33%MissN/A7N/AAug 10, 2021
    Mar 31, 2021-$0.45-$0.48-$0.51 - -$0.45+6.25%BeatN/A7N/AMay 6, 2021
    Dec 31, 2020-$0.84-$0.46-$0.69 - -$0.36-82.61%MissN/A6N/AMar 23, 2021
    Sep 30, 2020-$0.84-$0.39-$0.43 - -$0.33-115.38%MissN/A7N/ANov 5, 2020
    Jun 30, 2020-$0.51-$0.40-$0.67 - -$0.21-27.50%MissN/A6N/AAug 5, 2020
    Mar 31, 2020-$0.42-$0.46N/A+8.70%BeatN/AN/AN/AApr 23, 2020
    Dec 31, 2019-$0.08N/AN/AN/AN/AN/AN/AN/AFeb 28, 2020
    Last 27 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.52, after -$1.82 the year before. It was -$0.08 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.52N/A
    Dec 31, 2024-$1.82N/A
    Dec 31, 2023-$1.96N/A
    Dec 31, 2022-$2.25N/A
    Dec 31, 2021-$2.07N/A
    Dec 31, 2020-$2.61N/A
    Dec 31, 2019-$0.08N/A

    Frequently Asked Questions About ORIC

    When is Oric Pharmaceuticals's next earnings date?

    Oric Pharmaceuticals's next earnings report is expected for Feb 22, 2027.

    Did ORIC beat earnings estimates last quarter?

    No. Oric Pharmaceuticals reported EPS of -$0.38 for the quarter ended Jun 30, 2026, below the -$0.36 estimate by 5.56%.

    What EPS do analysts expect from ORIC next quarter?

    The consensus EPS estimate for Oric Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.41 from 16 analysts, with estimates from -$0.46 to -$0.35.

    How often does ORIC beat earnings estimates?

    Oric Pharmaceuticals beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +3.57%.